fulvestrant has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annepu, J; Diwakar, L; Kenchappa, RS; Ravindranath, V | 1 |
| Bains, M; Cousins, JC; Roberts, JL | 1 |
2 other study(ies) available for fulvestrant and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Electron Transport Complex I; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Glutaredoxins; Glutathione; Male; Mesencephalon; Mice; Mitochondria; Nerve Tissue Proteins; Neurotoxins; Oxidoreductases; Parkinsonian Disorders; Receptors, Estrogen; Sex Characteristics; Tyrosine 3-Monooxygenase; Ubiquinone | 2004 |
Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERalpha in primary cultures of mouse mesencephalon.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Astrocytes; Cells, Cultured; Dopamine; Drug Interactions; Embryo, Mammalian; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Pregnancy; Time Factors; Tyrosine 3-Monooxygenase | 2007 |